The Role of Esketamine in the Treatment of TRD

Video
Experts on depression.

Merrideth Leggat, MD, reviews clinical and practical implications of findings from the TRANSFORM and SUSTAIN studies exploring the utility of esketamine in the treatment of TRD.

Related Videos
Sejal Shah, MD | Credit: Brigham and Women's
Insight on the Promising 52-Week KarXT Data with Rishi Kakar, MD
Sunny Rai, PhD: “I” Language Markers Do Not Detect Depression in Black Individuals
Rebecca A. Andrews, MD: Issues and Steps to Improve MDD Performance Measures
A Voice Detecting Depression? Lindsey Venesky, PhD, Discusses New Data
Daniel Karlin, MD: FDA Grants Breakthrough Designation to MM120 for Anxiety
Related Content
Phase 2 SAVITRI Supports Use of NBI-1065845 in Major Depressive Disorder with Inadequate Response to Antidepressants ||| Depressed man on floor. | Credit: HolgersFotografie | Pixabay

Phase 2 SAVITRI Supports Use of NBI-1065845 in Major Depressive Disorder with Inadequate Response to Antidepressants

April 23rd 2024
Article
The Physician Burnout Crisis, with Sue Padernacht, EDd, PCC

The Physician Burnout Crisis, with Sue Padernacht, EDd, PCC

January 11th 2024
Podcast
| Image Credit: Seoul National University Hospital

Visual Impairment Associated with Heightened Risk of Suicidal Tendencies

April 17th 2024
Article
John J. Miller, MD: A New Era For Psychiatric Medications

John J. Miller, MD: A New Era For Psychiatric Medications

August 18th 2022
Podcast
Extending Postpartum Medicaid Linked to Increased Perinatal Mental Health Care

Extending Postpartum Medicaid Linked to Increased Perinatal Mental Health Care

April 12th 2024
Article
Single Dose of Esketamine After Childbirth Reduces Postpartum Depression

Single Dose of Esketamine After Childbirth Reduces Postpartum Depression

April 11th 2024
Article
© 2024 MJH Life Sciences

All rights reserved.